Clinical trials: Schizoaffecitve Disorder
Psychotic Disorder, Schizoaffecitve Disorder
Glycine to Treat Psychotic Disorders in Children
This study will test the safety and effectiveness of the amino acid glycine in treating psychotic disorders in children. The drug will be given as an adjunct (in addition) to the patient's current antipsychotic medication.
- Conditions
- Psychotic Disorder, Schizoaffecitve Disorder, Schizophrenia
- Trial name
- NCT00005658
- Testing
- Glycine
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- National Institute of Mental Health (NIMH)